News | Peripheral Artery Disease (PAD) | May 14, 2018

SCAI Launches Diagnosis and Treatment Toolkit for Peripheral Artery Disease

Online resource will provide patient-centered information on PAD risk factors, therapies and patient education

SCAI Launches Diagnosis and Treatment Toolkit for Peripheral Artery Disease

May 14, 2018 — The Society for Cardiovascular Angiography and Interventions (SCAI) announced the launch of the SCAI PAD Diagnosis and Treatment Resource Center. This center will be an ongoing, patient-centered quality improvement initiative focused on helping increase peripheral artery disease (PAD) awareness in the cardiovascular and internal medicine community by delving into the underlying risks of this disease state.

PAD impacts more than 10 million patients in the United States alone yet is woefully underdiagnosed. Lack of screening, underdiagnosis and undertreatment of PAD represent a critical gap in service to patients, as even asymptomatic PAD status is associated with the high long-term cardiovascular morbidity and mortality. Therefore, PAD has been targeted as one of SCAI’s key areas for quality improvement.

“I am excited to co-chair this important SCAI initiative on PAD awareness and education,” said Rajesh Swaminathan, M.D., FSCAI. “The condition is nearly as prevalent as CAD [coronary artery disease], yet still underdiagnosed. Early identification of PAD is key to proper counseling, risk factor modification and management to prevent future adverse clinical outcomes. The goal here is to provide PAD education, with incorporation of new clinical data in various formats, to inform and engage referring physicians, advanced practice providers, and fellows-in-training,” said Swaminathan.

The initiative also aims to improve the management and outcomes for PAD patients by providing a comprehensive review of “PAD 101.” This includes comprehensive discussions of:

  • Emerging data for secondary prevention in stable PAD;
  • Presentations to understand how to manage PAD patients; and
  • When to refer PAD patients for invasive therapies.

The multiyear program will be comprised of the following components:

  • The PAD Diagnosis and Treatment Resource Center: A five-part modular resource center hosted on SCAI’s website and packaged for easy download and dissemination; and
  • Webcast Series: A series of 30-minute webcasts based upon the PAD Diagnosis and Treatment Resource Center topics.

“The invasive therapy module will provide an evidence-based overview of the benefits of endovascular therapy and will help to clarify which patients should be considered for such therapy,” said Dmitriy Feldman, M.D., FSCAI, co-chair of the working group. “Furthermore, this module will focus on the SCAI-led Appropriate Use Criteria in EVT document as well as the newly released at SCAI 2018 Consensus Guidelines for Device Selection in Femoral-Popliteal Arterial Interventions.”

For more information:


Related Content

Livongo Launches Applied Health Signals Product Category
News | Cardiac Diagnostics | November 30, 2018
Healthcare technology company Livongo recently announced the launch of its Applied Health Signals product category,...
HHS Releases Second Edition of Physical Activity Guidelines for Americans. #AHA2018 #AHA18
News | Cardiac Diagnostics | November 14, 2018
The U.S. Department of Health and Human Services (HHS) released the second edition of the Physical Activity Guidelines...
ACC and AHA Release Updated Cholesterol Guidelines for 2018. #AHA18 #AHA2018
Feature | Cardiac Diagnostics | November 13, 2018
November 13, 2018 — New cholesterol guidelines from the American Heart Association (AHA) and the American College of
AMI READMITS Score Predicts Heart Attack Patients at High Readmission Risk
News | Cardiac Diagnostics | October 09, 2018
Tracking just seven factors of heart attack patients when they are first admitted to the hospital can help flag those...
Siemens Healthineers Showcases New In Vivo and In Vitro Cardiovascular Solutions at TCT 2018
News | Cardiac Diagnostics | September 21, 2018
At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego, Siemens Healthineers...
Weight Loss Drug Does Not Increase Cardiovascular Events
News | Cardiac Diagnostics | August 31, 2018
A weight loss drug does not increase cardiovascular events, according to late breaking results from the CAMELLIA-TIMI...
Acarix Presents CADScor System at ESC 2018
News | Cardiac Diagnostics | August 27, 2018
Acarix AB’s ultra-sensitive acoustic CADScor System for coronary artery disease risk assessment will be on display at...
NIH Ending Funding for Moderate Alcohol and Cardiovascular Health Trial
News | Cardiac Diagnostics | August 24, 2018
The National Institutes of Health announced in June it plans to end funding to the Moderate Alcohol and Cardiovascular...
Study Shows Multiple Benefits of Patient-to-Patient Connectivity in Familial Chylomicronemia Syndrome
News | Cardiac Diagnostics | August 07, 2018
Akcea Therapeutics Inc., an affiliate of Ionis Pharmaceuticals Inc., announced the publication of results from the...
Being Overweight May Change Young Adults' Heart Structure, Function
News | Cardiac Diagnostics | August 03, 2018
Even as a young adult, being overweight may cause higher blood pressure and thicken heart muscle, setting the stage for...
Overlay Init